Brian M. Wolpin, Zev A. Wainberg, Andrew Hendifar, Mitesh J. Borad, Filippo Pietrantonio, Shubham Pant, Pascal Hammel, Chiara Cremolini, Gulam Abbas Manji, Paul Eliezer Oberstein, Ignacio Garrido-Laguna, Christoph Springfeld, Nilofer Saba Azad, Makoto Ueno, Stephen Y. Chui, Ying Zhang, Hina Patel, Yeonju Lee, Zeena Salman, Eileen M. O'Reilly. "Daraxonrasib, a RAS(ON) multi-selective inhibitor vs chemotherapy in previously treated metastatic pancreatic adenocarcinoma (mPDAC): Primary and final analysis from the phase 3 RASolute 302 study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.17_suppl.lba5